PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 45 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,461 | +235.1% | 112,285 | +86.1% | 0.00% | – |
| Q2 2023 | $9,984 | -95.9% | 60,326 | -75.9% | 0.00% | – |
| Q1 2023 | $244,000 | +508233.3% | 250,004 | +437.2% | 0.00% | – |
| Q4 2022 | $48 | -98.4% | 46,541 | +1534.2% | 0.00% | – |
| Q3 2022 | $3,000 | -76.9% | 2,848 | -60.7% | 0.00% | – |
| Q2 2022 | $13,000 | -93.3% | 7,239 | -88.6% | 0.00% | – |
| Q1 2022 | $193,000 | +99.0% | 63,643 | +149.9% | 0.00% | – |
| Q4 2021 | $97,000 | -79.9% | 25,464 | -72.7% | 0.00% | – |
| Q3 2021 | $482,000 | +826.9% | 93,168 | +592.5% | 0.00% | – |
| Q2 2021 | $52,000 | -89.6% | 13,453 | -93.1% | 0.00% | – |
| Q1 2021 | $499,000 | +4.2% | 194,392 | +1.6% | 0.00% | – |
| Q4 2020 | $479,000 | +1160.5% | 191,347 | +934.6% | 0.00% | – |
| Q3 2020 | $38,000 | -26.9% | 18,495 | +10.2% | 0.00% | – |
| Q2 2020 | $52,000 | +52.9% | 16,783 | +12.8% | 0.00% | – |
| Q1 2020 | $34,000 | -38.2% | 14,884 | -1.9% | 0.00% | – |
| Q4 2019 | $55,000 | -32.9% | 15,173 | -37.0% | 0.00% | – |
| Q3 2019 | $82,000 | -78.4% | 24,071 | -71.9% | 0.00% | – |
| Q2 2019 | $379,000 | +321.1% | 85,549 | +216.5% | 0.00% | – |
| Q1 2019 | $90,000 | -30.2% | 27,030 | -44.2% | 0.00% | – |
| Q4 2018 | $129,000 | +92.5% | 48,460 | +303.0% | 0.00% | – |
| Q3 2018 | $67,000 | +26.4% | 12,026 | +14.1% | 0.00% | – |
| Q2 2018 | $53,000 | -95.7% | 10,544 | -94.2% | 0.00% | – |
| Q1 2018 | $1,245,000 | +86.4% | 182,575 | +106.4% | 0.00% | – |
| Q4 2017 | $668,000 | +11.3% | 88,454 | -13.3% | 0.00% | – |
| Q3 2017 | $600,000 | +883.6% | 102,076 | +333.4% | 0.00% | – |
| Q1 2017 | $61,000 | +90.6% | 23,552 | +34.6% | 0.00% | – |
| Q3 2016 | $32,000 | – | 17,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,136,319 | $3,443,000 | 3.20% |
| Aquilo Capital Management, LLC | 3,708,882 | $11,238,000 | 1.65% |
| Soleus Capital Management, L.P. | 4,134,868 | $12,529,000 | 1.62% |
| GREAT POINT PARTNERS LLC | 2,199,076 | $6,663,000 | 1.61% |
| BVF INC/IL | 5,328,239 | $16,145,000 | 0.65% |
| Cutter & CO Brokerage, Inc. | 406,229 | $1,231,000 | 0.37% |
| WEALTH EFFECTS LLC | 80,400 | $244,000 | 0.11% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,028,322 | $3,116,000 | 0.10% |
| Rhenman & Partners Asset Management AB | 300,000 | $909,000 | 0.09% |
| Woodline Partners LP | 1,587,475 | $4,810,000 | 0.08% |